Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Positron-Emission Tomography | 41 | 2024 | 6545 | 3.280 |
Why?
|
Granzymes | 5 | 2024 | 278 | 2.520 |
Why?
|
Molecular Imaging | 13 | 2023 | 822 | 2.270 |
Why?
|
Spectroscopy, Near-Infrared | 19 | 2012 | 749 | 1.880 |
Why?
|
Receptor, erbB-3 | 4 | 2024 | 141 | 1.770 |
Why?
|
Cryosurgery | 2 | 2024 | 479 | 1.260 |
Why?
|
Immunotherapy | 7 | 2024 | 4746 | 1.210 |
Why?
|
Fluorescent Dyes | 24 | 2020 | 1928 | 1.190 |
Why?
|
Mice, Nude | 31 | 2022 | 3610 | 1.190 |
Why?
|
Nuclear Medicine | 3 | 2015 | 261 | 1.160 |
Why?
|
Molecular Probe Techniques | 5 | 2010 | 111 | 1.140 |
Why?
|
Radiopharmaceuticals | 20 | 2022 | 2702 | 1.130 |
Why?
|
Cathepsin B | 9 | 2020 | 80 | 1.080 |
Why?
|
Colonic Neoplasms | 12 | 2018 | 2532 | 1.080 |
Why?
|
Spectrometry, Fluorescence | 10 | 2013 | 694 | 1.050 |
Why?
|
Medical Oncology | 5 | 2023 | 2339 | 1.040 |
Why?
|
Receptors, Somatostatin | 3 | 2018 | 138 | 1.000 |
Why?
|
Fluorine Radioisotopes | 3 | 2018 | 399 | 0.930 |
Why?
|
Mice | 108 | 2024 | 81839 | 0.920 |
Why?
|
Cell Line, Tumor | 34 | 2024 | 17071 | 0.910 |
Why?
|
Matrix Metalloproteinases | 4 | 2015 | 392 | 0.900 |
Why?
|
Glycolates | 1 | 2023 | 41 | 0.890 |
Why?
|
Neoplasms | 16 | 2023 | 22344 | 0.860 |
Why?
|
Fluorodeoxyglucose F18 | 14 | 2022 | 2029 | 0.800 |
Why?
|
Animals | 128 | 2024 | 168800 | 0.780 |
Why?
|
Cathepsins | 4 | 2008 | 242 | 0.770 |
Why?
|
Neoplasms, Experimental | 7 | 2016 | 1227 | 0.770 |
Why?
|
Ductus Arteriosus | 1 | 2021 | 42 | 0.740 |
Why?
|
Microscopy, Fluorescence | 13 | 2014 | 2627 | 0.740 |
Why?
|
Persistent Fetal Circulation Syndrome | 1 | 2021 | 80 | 0.720 |
Why?
|
Gallium Radioisotopes | 4 | 2023 | 195 | 0.700 |
Why?
|
Methionine | 2 | 2022 | 569 | 0.680 |
Why?
|
Molecular Targeted Therapy | 5 | 2018 | 2824 | 0.670 |
Why?
|
Ductus Arteriosus, Patent | 1 | 2021 | 216 | 0.650 |
Why?
|
Colorectal Neoplasms | 10 | 2019 | 6961 | 0.640 |
Why?
|
Arthritis, Experimental | 7 | 2014 | 291 | 0.640 |
Why?
|
Disease Models, Animal | 30 | 2024 | 18321 | 0.620 |
Why?
|
Genes, cdc | 1 | 2018 | 113 | 0.610 |
Why?
|
Carcinoma, Hepatocellular | 3 | 2021 | 2327 | 0.600 |
Why?
|
Stomach Neoplasms | 3 | 2024 | 1471 | 0.600 |
Why?
|
Octreotide | 3 | 2023 | 157 | 0.600 |
Why?
|
Catheterization | 4 | 2007 | 1426 | 0.590 |
Why?
|
Adenocarcinoma | 14 | 2016 | 6363 | 0.580 |
Why?
|
Sodium Fluoride | 1 | 2017 | 60 | 0.580 |
Why?
|
Liver Neoplasms | 5 | 2021 | 4352 | 0.580 |
Why?
|
Dihydrotestosterone | 1 | 2018 | 194 | 0.570 |
Why?
|
Endocarditis | 1 | 2021 | 349 | 0.550 |
Why?
|
Chest Pain | 1 | 2024 | 1102 | 0.550 |
Why?
|
Misonidazole | 2 | 2015 | 33 | 0.530 |
Why?
|
Organometallic Compounds | 2 | 2023 | 645 | 0.520 |
Why?
|
Spectrophotometry, Infrared | 2 | 2007 | 116 | 0.520 |
Why?
|
Antineoplastic Agents | 12 | 2021 | 13635 | 0.510 |
Why?
|
Esophageal Neoplasms | 4 | 2015 | 1659 | 0.510 |
Why?
|
Breast Neoplasms | 12 | 2024 | 21074 | 0.510 |
Why?
|
Neoplasm Transplantation | 14 | 2018 | 2010 | 0.510 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2018 | 557 | 0.500 |
Why?
|
Intestinal Neoplasms | 4 | 2013 | 314 | 0.490 |
Why?
|
Neuroendocrine Tumors | 3 | 2023 | 657 | 0.490 |
Why?
|
Receptor, erbB-2 | 5 | 2024 | 2593 | 0.490 |
Why?
|
Peptides | 5 | 2018 | 4338 | 0.490 |
Why?
|
Magnetic Resonance Imaging | 33 | 2023 | 36548 | 0.490 |
Why?
|
Endoscopes | 2 | 2007 | 169 | 0.470 |
Why?
|
Contrast Media | 11 | 2023 | 5330 | 0.470 |
Why?
|
Prostatic Neoplasms | 11 | 2022 | 11094 | 0.470 |
Why?
|
Radiology | 4 | 2023 | 2105 | 0.470 |
Why?
|
Peritoneal Neoplasms | 3 | 2022 | 706 | 0.470 |
Why?
|
Ferrosoferric Oxide | 2 | 2014 | 349 | 0.460 |
Why?
|
Antineoplastic Agents, Hormonal | 4 | 2017 | 1535 | 0.450 |
Why?
|
Osteoclasts | 2 | 2008 | 713 | 0.440 |
Why?
|
Image Interpretation, Computer-Assisted | 4 | 2007 | 3360 | 0.430 |
Why?
|
Receptors, Estrogen | 4 | 2024 | 2242 | 0.430 |
Why?
|
Silicates | 1 | 2013 | 49 | 0.430 |
Why?
|
Bone and Bones | 5 | 2017 | 2555 | 0.420 |
Why?
|
Glass | 1 | 2013 | 116 | 0.420 |
Why?
|
Liver Neoplasms, Experimental | 1 | 2014 | 190 | 0.410 |
Why?
|
Neoadjuvant Therapy | 1 | 2024 | 2897 | 0.410 |
Why?
|
Radionuclide Imaging | 8 | 2015 | 1985 | 0.410 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2024 | 2431 | 0.410 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 2014 | 443 | 0.400 |
Why?
|
Cell Proliferation | 7 | 2016 | 10433 | 0.400 |
Why?
|
Carbocyanines | 8 | 2014 | 177 | 0.400 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2016 | 562 | 0.400 |
Why?
|
Multiple Myeloma | 2 | 2022 | 5189 | 0.400 |
Why?
|
Nanoparticles | 5 | 2016 | 1966 | 0.390 |
Why?
|
Tissue Distribution | 6 | 2021 | 2271 | 0.380 |
Why?
|
Humans | 114 | 2024 | 766117 | 0.380 |
Why?
|
Peptide Hydrolases | 4 | 2009 | 608 | 0.380 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2018 | 2838 | 0.380 |
Why?
|
Boron Compounds | 1 | 2013 | 195 | 0.380 |
Why?
|
Tumor Microenvironment | 4 | 2024 | 3942 | 0.370 |
Why?
|
Green Fluorescent Proteins | 7 | 2007 | 2062 | 0.370 |
Why?
|
Indicators and Reagents | 2 | 2009 | 456 | 0.370 |
Why?
|
Colonoscopy | 4 | 2016 | 1408 | 0.370 |
Why?
|
Referral and Consultation | 1 | 2024 | 3617 | 0.360 |
Why?
|
Whole Body Imaging | 2 | 2017 | 281 | 0.360 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2012 | 319 | 0.350 |
Why?
|
Gliosarcoma | 3 | 2006 | 115 | 0.350 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2017 | 1656 | 0.350 |
Why?
|
Mice, Inbred BALB C | 11 | 2016 | 6215 | 0.340 |
Why?
|
4-Chloro-7-nitrobenzofurazan | 1 | 2009 | 21 | 0.340 |
Why?
|
Endoscopy | 4 | 2014 | 1854 | 0.340 |
Why?
|
Endopeptidases | 3 | 2004 | 760 | 0.340 |
Why?
|
Colon | 3 | 2016 | 1797 | 0.330 |
Why?
|
Molecular Biology | 3 | 2005 | 573 | 0.330 |
Why?
|
Xenograft Model Antitumor Assays | 9 | 2018 | 3604 | 0.330 |
Why?
|
Nephritis | 1 | 2010 | 146 | 0.320 |
Why?
|
Bacteriocins | 1 | 2009 | 85 | 0.320 |
Why?
|
Antibodies, Monoclonal | 6 | 2016 | 9237 | 0.320 |
Why?
|
Tomography, Optical | 2 | 2007 | 129 | 0.320 |
Why?
|
Mammary Neoplasms, Experimental | 7 | 1999 | 496 | 0.320 |
Why?
|
Colonic Polyps | 3 | 2016 | 557 | 0.320 |
Why?
|
Deoxyglucose | 1 | 2009 | 322 | 0.320 |
Why?
|
Tomography | 3 | 2007 | 443 | 0.310 |
Why?
|
Cell Adhesion Molecules | 1 | 2015 | 1610 | 0.310 |
Why?
|
Autoimmune Diseases | 3 | 2010 | 2249 | 0.310 |
Why?
|
Carotid Artery, Common | 1 | 2009 | 172 | 0.310 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2016 | 1621 | 0.310 |
Why?
|
Estradiol | 2 | 2016 | 1947 | 0.310 |
Why?
|
Luminescent Proteins | 4 | 2007 | 839 | 0.300 |
Why?
|
Sensitivity and Specificity | 16 | 2022 | 14645 | 0.300 |
Why?
|
Abdominal Neoplasms | 2 | 2021 | 286 | 0.290 |
Why?
|
Androstenes | 1 | 2009 | 177 | 0.290 |
Why?
|
Diagnostic Imaging | 7 | 2008 | 3530 | 0.290 |
Why?
|
Nanostructures | 3 | 2009 | 549 | 0.280 |
Why?
|
Aorta, Abdominal | 1 | 2010 | 626 | 0.280 |
Why?
|
Prodrugs | 1 | 2009 | 274 | 0.280 |
Why?
|
Microfluidics | 1 | 2012 | 651 | 0.280 |
Why?
|
Biopsy | 3 | 2021 | 6768 | 0.270 |
Why?
|
Colonoscopes | 1 | 2006 | 17 | 0.270 |
Why?
|
Peroxidase | 1 | 2009 | 610 | 0.260 |
Why?
|
Gadolinium DTPA | 1 | 2009 | 822 | 0.260 |
Why?
|
Biomarkers, Pharmacological | 2 | 2017 | 161 | 0.260 |
Why?
|
Dermoscopy | 1 | 2006 | 73 | 0.260 |
Why?
|
Liver Diseases | 1 | 2014 | 1304 | 0.260 |
Why?
|
Carcinoma, Lewis Lung | 1 | 2006 | 106 | 0.260 |
Why?
|
HT29 Cells | 5 | 2014 | 187 | 0.250 |
Why?
|
Lung Neoplasms | 8 | 2021 | 13483 | 0.250 |
Why?
|
Glioblastoma | 2 | 2018 | 3458 | 0.250 |
Why?
|
Chemoembolization, Therapeutic | 1 | 2006 | 128 | 0.250 |
Why?
|
Pancreatic Neoplasms | 4 | 2018 | 5454 | 0.250 |
Why?
|
Thoracoscopy | 1 | 2006 | 186 | 0.240 |
Why?
|
Indocyanine Green | 3 | 2014 | 235 | 0.240 |
Why?
|
Endoscopy, Gastrointestinal | 2 | 2014 | 889 | 0.240 |
Why?
|
Metformin | 1 | 2013 | 903 | 0.240 |
Why?
|
Adenoma | 4 | 2016 | 2155 | 0.240 |
Why?
|
Mice, Inbred C57BL | 14 | 2024 | 22341 | 0.240 |
Why?
|
Microscopy, Confocal | 6 | 2014 | 1967 | 0.240 |
Why?
|
Mesenchymal Stem Cell Transplantation | 2 | 2013 | 504 | 0.240 |
Why?
|
Lipogenesis | 2 | 2018 | 217 | 0.230 |
Why?
|
Gene Transfer Techniques | 2 | 2006 | 1206 | 0.230 |
Why?
|
Female | 50 | 2024 | 396233 | 0.230 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2015 | 4049 | 0.220 |
Why?
|
Magnetic Resonance Spectroscopy | 12 | 2022 | 3678 | 0.220 |
Why?
|
Lung | 4 | 2021 | 10063 | 0.220 |
Why?
|
Pyrazoles | 2 | 2017 | 2031 | 0.210 |
Why?
|
Carotid Artery Diseases | 1 | 2009 | 872 | 0.210 |
Why?
|
Genes, Reporter | 3 | 2018 | 1524 | 0.200 |
Why?
|
Sulfonamides | 1 | 2012 | 1980 | 0.200 |
Why?
|
Gene Expression | 5 | 2016 | 7582 | 0.200 |
Why?
|
Colitis, Ulcerative | 1 | 2014 | 1912 | 0.200 |
Why?
|
Aorta | 2 | 2009 | 2040 | 0.190 |
Why?
|
Fibrin | 1 | 2024 | 514 | 0.190 |
Why?
|
Pandemics | 2 | 2023 | 8725 | 0.190 |
Why?
|
Coloring Agents | 2 | 2014 | 563 | 0.190 |
Why?
|
Tumor Cells, Cultured | 9 | 2013 | 6102 | 0.190 |
Why?
|
Dose-Response Relationship, Drug | 8 | 2016 | 10737 | 0.190 |
Why?
|
Oxygen | 2 | 2012 | 4247 | 0.190 |
Why?
|
Protein Binding | 4 | 2018 | 9301 | 0.190 |
Why?
|
Early Diagnosis | 4 | 2012 | 1186 | 0.180 |
Why?
|
Gastrointestinal Tract | 2 | 2018 | 834 | 0.180 |
Why?
|
Copper Radioisotopes | 2 | 2024 | 99 | 0.180 |
Why?
|
International Educational Exchange | 1 | 2020 | 54 | 0.170 |
Why?
|
Rats | 12 | 2013 | 23717 | 0.170 |
Why?
|
Radiology, Interventional | 1 | 2004 | 484 | 0.170 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2010 | 1249 | 0.170 |
Why?
|
Paclitaxel | 1 | 2007 | 1727 | 0.170 |
Why?
|
Fluorescence | 3 | 2008 | 751 | 0.170 |
Why?
|
Male | 41 | 2024 | 363935 | 0.170 |
Why?
|
AMP-Activated Protein Kinases | 2 | 2014 | 594 | 0.170 |
Why?
|
6-Aminonicotinamide | 2 | 1996 | 8 | 0.170 |
Why?
|
Ovarian Neoplasms | 2 | 2009 | 4904 | 0.170 |
Why?
|
Carbon Radioisotopes | 2 | 2019 | 543 | 0.170 |
Why?
|
Carcinoma, Ductal, Breast | 2 | 2017 | 1086 | 0.170 |
Why?
|
Indoles | 3 | 2014 | 1833 | 0.160 |
Why?
|
Tomography, X-Ray Computed | 8 | 2021 | 20700 | 0.160 |
Why?
|
Intracranial Aneurysm | 1 | 2009 | 1271 | 0.160 |
Why?
|
Gene Expression Regulation, Neoplastic | 6 | 2024 | 8612 | 0.160 |
Why?
|
Optics and Photonics | 3 | 2007 | 305 | 0.160 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2007 | 958 | 0.160 |
Why?
|
Urologic Neoplasms | 1 | 2023 | 312 | 0.160 |
Why?
|
Mice, Transgenic | 13 | 2014 | 9540 | 0.160 |
Why?
|
Cyclobutanes | 1 | 2019 | 57 | 0.160 |
Why?
|
Carboxylic Acids | 1 | 2019 | 91 | 0.150 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2015 | 5388 | 0.150 |
Why?
|
Treatment Outcome | 9 | 2019 | 65219 | 0.150 |
Why?
|
Melanoma | 1 | 2017 | 5695 | 0.150 |
Why?
|
Radiology Information Systems | 1 | 2023 | 535 | 0.150 |
Why?
|
Societies, Medical | 2 | 2020 | 3955 | 0.150 |
Why?
|
Adjuvants, Immunologic | 1 | 2023 | 993 | 0.150 |
Why?
|
Abdomen | 3 | 2023 | 1135 | 0.150 |
Why?
|
Neutrophils | 3 | 2009 | 3771 | 0.150 |
Why?
|
Software | 3 | 2007 | 4463 | 0.150 |
Why?
|
Cathepsin K | 2 | 2008 | 65 | 0.150 |
Why?
|
Respiratory-Gated Imaging Techniques | 1 | 2018 | 73 | 0.140 |
Why?
|
Magnetite Nanoparticles | 2 | 2013 | 309 | 0.140 |
Why?
|
Pilot Projects | 3 | 2022 | 8724 | 0.140 |
Why?
|
Glutamate Carboxypeptidase II | 1 | 2018 | 90 | 0.140 |
Why?
|
Herpesvirus 1, Human | 1 | 2023 | 743 | 0.140 |
Why?
|
Endothelium, Vascular | 1 | 2009 | 4423 | 0.140 |
Why?
|
Imaging, Three-Dimensional | 2 | 2007 | 4044 | 0.140 |
Why?
|
North America | 1 | 2020 | 1287 | 0.140 |
Why?
|
Mice, Inbred Strains | 3 | 2015 | 1769 | 0.140 |
Why?
|
Drug Delivery Systems | 1 | 2008 | 2210 | 0.140 |
Why?
|
Biotin | 1 | 2018 | 255 | 0.140 |
Why?
|
Neoplasm Staging | 8 | 2020 | 11200 | 0.140 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2002 | 844 | 0.140 |
Why?
|
Cinnamates | 1 | 2016 | 59 | 0.140 |
Why?
|
Indazoles | 2 | 2016 | 306 | 0.130 |
Why?
|
Immunosuppressive Agents | 1 | 2009 | 4213 | 0.130 |
Why?
|
Image Enhancement | 4 | 2009 | 2857 | 0.130 |
Why?
|
Equipment Design | 4 | 2008 | 3489 | 0.130 |
Why?
|
Feasibility Studies | 6 | 2009 | 5300 | 0.130 |
Why?
|
Cell Adhesion | 2 | 2015 | 3089 | 0.130 |
Why?
|
Quinazolines | 2 | 2021 | 1366 | 0.130 |
Why?
|
Phantoms, Imaging | 4 | 2014 | 2474 | 0.130 |
Why?
|
Pentose Phosphate Pathway | 1 | 1996 | 125 | 0.130 |
Why?
|
Cell Hypoxia | 2 | 2015 | 656 | 0.130 |
Why?
|
Teratogens | 1 | 1996 | 120 | 0.120 |
Why?
|
Inflammation | 8 | 2014 | 10860 | 0.120 |
Why?
|
Middle Aged | 21 | 2024 | 223083 | 0.120 |
Why?
|
Lactams, Macrocyclic | 1 | 2017 | 318 | 0.120 |
Why?
|
Ovariectomy | 2 | 2008 | 612 | 0.120 |
Why?
|
Up-Regulation | 6 | 2013 | 4133 | 0.120 |
Why?
|
Osteogenesis | 1 | 2002 | 1281 | 0.120 |
Why?
|
Mesenchymal Stem Cells | 2 | 2018 | 1663 | 0.120 |
Why?
|
Genes, APC | 3 | 2013 | 144 | 0.120 |
Why?
|
Diffusion Magnetic Resonance Imaging | 2 | 2017 | 2805 | 0.120 |
Why?
|
Internationality | 1 | 2020 | 1007 | 0.120 |
Why?
|
Heterocyclic Compounds, 1-Ring | 1 | 2015 | 68 | 0.120 |
Why?
|
Energy Metabolism | 3 | 1995 | 2894 | 0.120 |
Why?
|
Prospective Studies | 5 | 2024 | 54812 | 0.120 |
Why?
|
Genetic Markers | 1 | 2001 | 2603 | 0.120 |
Why?
|
Combined Modality Therapy | 3 | 2024 | 8525 | 0.120 |
Why?
|
Receptors, Chemokine | 1 | 2018 | 651 | 0.120 |
Why?
|
Aged | 16 | 2024 | 171219 | 0.120 |
Why?
|
Arthritis, Rheumatoid | 3 | 2007 | 3743 | 0.120 |
Why?
|
Pyrroles | 2 | 2012 | 1120 | 0.120 |
Why?
|
Reproducibility of Results | 6 | 2016 | 20137 | 0.120 |
Why?
|
Bone Density | 1 | 2007 | 3491 | 0.110 |
Why?
|
Molecular Probes | 2 | 2008 | 309 | 0.110 |
Why?
|
Enzyme Activators | 1 | 2014 | 56 | 0.110 |
Why?
|
Fiber Optic Technology | 2 | 2007 | 290 | 0.110 |
Why?
|
Hindlimb | 2 | 2014 | 512 | 0.110 |
Why?
|
Brain Neoplasms | 4 | 2013 | 9065 | 0.110 |
Why?
|
Cholangiocarcinoma | 1 | 2019 | 577 | 0.110 |
Why?
|
Bile Duct Neoplasms | 1 | 2019 | 624 | 0.110 |
Why?
|
Chemical Fractionation | 1 | 2013 | 60 | 0.110 |
Why?
|
Biological Transport | 1 | 2018 | 2080 | 0.110 |
Why?
|
Algorithms | 4 | 2009 | 14066 | 0.110 |
Why?
|
Public Policy | 1 | 2018 | 551 | 0.110 |
Why?
|
Antigens, Surface | 1 | 2018 | 1616 | 0.110 |
Why?
|
Denervation | 1 | 2014 | 265 | 0.110 |
Why?
|
Prognosis | 7 | 2018 | 29912 | 0.110 |
Why?
|
Postoperative Period | 1 | 2018 | 1820 | 0.110 |
Why?
|
Neoplasm, Residual | 1 | 2018 | 1009 | 0.100 |
Why?
|
Liver | 1 | 2008 | 7559 | 0.100 |
Why?
|
Signal Transduction | 7 | 2024 | 23605 | 0.100 |
Why?
|
Dimethyl Sulfoxide | 1 | 2014 | 250 | 0.100 |
Why?
|
Oropharyngeal Neoplasms | 1 | 2018 | 492 | 0.100 |
Why?
|
Gene Expression Profiling | 3 | 2013 | 9527 | 0.100 |
Why?
|
Luminescent Measurements | 1 | 2014 | 341 | 0.100 |
Why?
|
Estrogen Receptor alpha | 1 | 2016 | 580 | 0.100 |
Why?
|
Technetium Tc 99m Medronate | 1 | 2012 | 134 | 0.100 |
Why?
|
Animals, Newborn | 2 | 2008 | 2677 | 0.100 |
Why?
|
Receptors, Androgen | 1 | 2018 | 1088 | 0.100 |
Why?
|
Papillomaviridae | 1 | 2018 | 1137 | 0.100 |
Why?
|
Immunologic Factors | 1 | 2021 | 1592 | 0.100 |
Why?
|
Protein-Tyrosine Kinases | 3 | 2022 | 2425 | 0.100 |
Why?
|
Cardia | 1 | 2012 | 61 | 0.100 |
Why?
|
Staining and Labeling | 2 | 2020 | 1072 | 0.100 |
Why?
|
Solubility | 1 | 2013 | 1077 | 0.100 |
Why?
|
Rectal Neoplasms | 1 | 2020 | 1183 | 0.090 |
Why?
|
DNA, Viral | 1 | 2018 | 2200 | 0.090 |
Why?
|
Fibroblasts | 2 | 2014 | 4162 | 0.090 |
Why?
|
Immunohistochemistry | 5 | 2015 | 11035 | 0.090 |
Why?
|
Carcinoma, Pancreatic Ductal | 3 | 2014 | 1762 | 0.090 |
Why?
|
Bone Neoplasms | 3 | 2015 | 2559 | 0.090 |
Why?
|
Transfection | 3 | 2004 | 5739 | 0.090 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2021 | 5336 | 0.090 |
Why?
|
Incidental Findings | 1 | 2016 | 698 | 0.090 |
Why?
|
Esophagoscopy | 1 | 2012 | 398 | 0.090 |
Why?
|
Esophagitis | 1 | 2012 | 163 | 0.090 |
Why?
|
Image Processing, Computer-Assisted | 8 | 2023 | 8924 | 0.090 |
Why?
|
Calcium Chloride | 1 | 2010 | 78 | 0.090 |
Why?
|
Orchiectomy | 1 | 2012 | 465 | 0.090 |
Why?
|
DNA Mismatch Repair | 1 | 2013 | 432 | 0.090 |
Why?
|
Oncolytic Viruses | 1 | 2014 | 344 | 0.090 |
Why?
|
Length of Stay | 1 | 2024 | 6490 | 0.090 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2017 | 1801 | 0.080 |
Why?
|
Retrospective Studies | 10 | 2021 | 81565 | 0.080 |
Why?
|
Parents | 1 | 2024 | 3591 | 0.080 |
Why?
|
Cyclooxygenase 2 | 1 | 2012 | 595 | 0.080 |
Why?
|
Microvessels | 1 | 2014 | 590 | 0.080 |
Why?
|
Gastrointestinal Diseases | 1 | 2018 | 1204 | 0.080 |
Why?
|
Disease-Free Survival | 3 | 2017 | 6840 | 0.080 |
Why?
|
Rats, Sprague-Dawley | 3 | 2010 | 8113 | 0.080 |
Why?
|
Chondrocytes | 1 | 2015 | 798 | 0.080 |
Why?
|
Congresses as Topic | 1 | 2014 | 811 | 0.080 |
Why?
|
Bile Acids and Salts | 1 | 2012 | 398 | 0.080 |
Why?
|
Cells, Cultured | 5 | 2015 | 18967 | 0.080 |
Why?
|
Nanotechnology | 3 | 2013 | 702 | 0.080 |
Why?
|
Cryoultramicrotomy | 1 | 2008 | 16 | 0.080 |
Why?
|
Polymerase Chain Reaction | 1 | 2018 | 6059 | 0.080 |
Why?
|
Simplexvirus | 3 | 2013 | 805 | 0.080 |
Why?
|
Mice, Inbred C3H | 5 | 1997 | 915 | 0.080 |
Why?
|
Neoplasm Proteins | 2 | 2018 | 3594 | 0.080 |
Why?
|
Neoplasm Invasiveness | 2 | 2015 | 3602 | 0.080 |
Why?
|
Sex Characteristics | 1 | 2019 | 2646 | 0.080 |
Why?
|
Education, Medical | 1 | 2020 | 1744 | 0.080 |
Why?
|
Matrix Metalloproteinase 2 | 2 | 2020 | 462 | 0.080 |
Why?
|
Plectin | 1 | 2008 | 14 | 0.080 |
Why?
|
Genes, p53 | 2 | 2013 | 711 | 0.080 |
Why?
|
Thymidine Kinase | 2 | 2023 | 286 | 0.080 |
Why?
|
Oncolytic Virotherapy | 1 | 2014 | 520 | 0.080 |
Why?
|
Cell Cycle | 2 | 2013 | 2920 | 0.080 |
Why?
|
Apoptosis | 4 | 2013 | 9508 | 0.080 |
Why?
|
Androgen Antagonists | 1 | 2017 | 1411 | 0.070 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2009 | 182 | 0.070 |
Why?
|
Protein Kinase Inhibitors | 5 | 2022 | 5695 | 0.070 |
Why?
|
Annexins | 1 | 2007 | 39 | 0.070 |
Why?
|
Calcification, Physiologic | 1 | 2008 | 167 | 0.070 |
Why?
|
Doxycycline | 1 | 2010 | 348 | 0.070 |
Why?
|
Neovascularization, Pathologic | 3 | 2007 | 2627 | 0.070 |
Why?
|
Dilatation, Pathologic | 1 | 2009 | 527 | 0.070 |
Why?
|
Somatostatin | 2 | 2022 | 459 | 0.070 |
Why?
|
Methotrexate | 2 | 2005 | 1719 | 0.070 |
Why?
|
Barrett Esophagus | 1 | 2012 | 494 | 0.070 |
Why?
|
Photons | 2 | 2008 | 571 | 0.070 |
Why?
|
Spleen | 1 | 2014 | 2294 | 0.070 |
Why?
|
Androstadienes | 1 | 2009 | 347 | 0.070 |
Why?
|
Cell Membrane Permeability | 1 | 2009 | 565 | 0.070 |
Why?
|
ras Proteins | 1 | 2013 | 1054 | 0.070 |
Why?
|
Miniaturization | 2 | 2005 | 150 | 0.070 |
Why?
|
Extracellular Matrix | 1 | 2015 | 1727 | 0.070 |
Why?
|
Electrons | 1 | 2008 | 264 | 0.070 |
Why?
|
Stem Cells | 2 | 2012 | 3537 | 0.070 |
Why?
|
Fibrosis | 1 | 2014 | 2073 | 0.070 |
Why?
|
Critical Pathways | 2 | 2022 | 475 | 0.070 |
Why?
|
Subtraction Technique | 1 | 2010 | 513 | 0.070 |
Why?
|
Mice, Inbred DBA | 2 | 2005 | 624 | 0.070 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2013 | 2877 | 0.070 |
Why?
|
Protease Inhibitors | 1 | 2010 | 750 | 0.070 |
Why?
|
Heart Defects, Congenital | 1 | 2023 | 4712 | 0.070 |
Why?
|
Papillomavirus Infections | 1 | 2018 | 1637 | 0.070 |
Why?
|
Enzyme Activation | 4 | 2006 | 3584 | 0.070 |
Why?
|
Disease Progression | 6 | 2018 | 13616 | 0.070 |
Why?
|
Homeostasis | 1 | 2017 | 3338 | 0.070 |
Why?
|
Immunoenzyme Techniques | 2 | 2006 | 1695 | 0.070 |
Why?
|
Cell Survival | 4 | 2013 | 5747 | 0.070 |
Why?
|
Oncogene Protein p21(ras) | 1 | 2006 | 68 | 0.070 |
Why?
|
Neoplasm Metastasis | 3 | 2018 | 4887 | 0.070 |
Why?
|
Tumor Suppressor Protein p14ARF | 1 | 2006 | 84 | 0.070 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2012 | 3796 | 0.070 |
Why?
|
Dexamethasone | 1 | 2014 | 1962 | 0.060 |
Why?
|
Nonmuscle Myosin Type IIA | 1 | 2006 | 28 | 0.060 |
Why?
|
Computer Systems | 1 | 2007 | 468 | 0.060 |
Why?
|
Peritoneum | 1 | 2007 | 226 | 0.060 |
Why?
|
Antirheumatic Agents | 2 | 2007 | 1380 | 0.060 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2010 | 678 | 0.060 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2008 | 634 | 0.060 |
Why?
|
Phosphorus | 3 | 1996 | 336 | 0.060 |
Why?
|
Epigenesis, Genetic | 1 | 2019 | 3818 | 0.060 |
Why?
|
Leukocytes | 1 | 2014 | 2030 | 0.060 |
Why?
|
I-kappa B Kinase | 1 | 2007 | 250 | 0.060 |
Why?
|
Carboplatin | 1 | 2008 | 787 | 0.060 |
Why?
|
Capillary Permeability | 2 | 2006 | 770 | 0.060 |
Why?
|
Thiazolidinediones | 1 | 2008 | 460 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2019 | 9378 | 0.060 |
Why?
|
Bone Development | 1 | 2008 | 468 | 0.060 |
Why?
|
Glucose | 3 | 2013 | 4335 | 0.060 |
Why?
|
Mice, Inbred NOD | 3 | 2023 | 1837 | 0.060 |
Why?
|
Equipment Failure Analysis | 1 | 2007 | 831 | 0.060 |
Why?
|
Mice, Knockout | 7 | 2010 | 14456 | 0.060 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2006 | 220 | 0.060 |
Why?
|
Annexin A5 | 1 | 2005 | 102 | 0.060 |
Why?
|
Ferric Compounds | 2 | 2003 | 367 | 0.060 |
Why?
|
Carbolines | 1 | 2007 | 288 | 0.060 |
Why?
|
Bone Resorption | 1 | 2008 | 717 | 0.060 |
Why?
|
Niacinamide | 1 | 2007 | 419 | 0.060 |
Why?
|
Time Factors | 5 | 2013 | 40108 | 0.060 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 3690 | 0.060 |
Why?
|
Osteoarthritis, Knee | 1 | 2015 | 1248 | 0.060 |
Why?
|
Fracture Healing | 1 | 2007 | 448 | 0.060 |
Why?
|
Pancreatic Ducts | 1 | 2006 | 331 | 0.060 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2010 | 1765 | 0.060 |
Why?
|
Adult | 11 | 2024 | 223139 | 0.060 |
Why?
|
Aged, 80 and over | 4 | 2019 | 59515 | 0.060 |
Why?
|
Cerebral Angiography | 1 | 2009 | 1263 | 0.060 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2007 | 615 | 0.060 |
Why?
|
Monte Carlo Method | 1 | 2009 | 1238 | 0.050 |
Why?
|
Motion | 2 | 2018 | 782 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2013 | 11859 | 0.050 |
Why?
|
Histocytochemistry | 1 | 2004 | 695 | 0.050 |
Why?
|
Cell Count | 1 | 2007 | 1825 | 0.050 |
Why?
|
Rabbits | 1 | 2009 | 4730 | 0.050 |
Why?
|
Burns | 1 | 2014 | 1904 | 0.050 |
Why?
|
Cathepsin D | 2 | 2000 | 59 | 0.050 |
Why?
|
Infant, Newborn | 2 | 2021 | 26381 | 0.050 |
Why?
|
RNA, Messenger | 4 | 2008 | 12775 | 0.050 |
Why?
|
Bacteriophages | 1 | 2006 | 381 | 0.050 |
Why?
|
Oxides | 1 | 2004 | 402 | 0.050 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2006 | 702 | 0.050 |
Why?
|
Enzyme Inhibitors | 2 | 2018 | 3722 | 0.050 |
Why?
|
Dextrans | 1 | 2004 | 569 | 0.050 |
Why?
|
Receptors, IgG | 2 | 2006 | 559 | 0.050 |
Why?
|
CpG Islands | 1 | 2007 | 1207 | 0.050 |
Why?
|
Sirolimus | 1 | 2010 | 1541 | 0.050 |
Why?
|
Capillaries | 1 | 2006 | 751 | 0.050 |
Why?
|
Esophagus | 1 | 2008 | 1039 | 0.050 |
Why?
|
Lactate Dehydrogenases | 1 | 2022 | 25 | 0.050 |
Why?
|
Prostate-Specific Antigen | 3 | 2019 | 2463 | 0.050 |
Why?
|
Luciferases | 1 | 2004 | 712 | 0.050 |
Why?
|
Glioma | 2 | 2007 | 3491 | 0.050 |
Why?
|
Peptides, Cyclic | 1 | 2004 | 390 | 0.050 |
Why?
|
Neurofibromatosis 2 | 1 | 2006 | 387 | 0.050 |
Why?
|
Femur | 1 | 2008 | 1309 | 0.050 |
Why?
|
Developing Countries | 1 | 2014 | 2914 | 0.050 |
Why?
|
Cell Line | 4 | 2009 | 15546 | 0.050 |
Why?
|
Arthritis | 1 | 2007 | 676 | 0.050 |
Why?
|
Macrophage Activation | 1 | 2005 | 553 | 0.050 |
Why?
|
Glucose Transporter Type 1 | 1 | 2022 | 186 | 0.050 |
Why?
|
Hexokinase | 1 | 2022 | 125 | 0.050 |
Why?
|
Microradiography | 1 | 2001 | 13 | 0.050 |
Why?
|
Marmota | 1 | 2021 | 13 | 0.050 |
Why?
|
Spectrum Analysis | 2 | 2020 | 443 | 0.050 |
Why?
|
Antibodies | 1 | 2009 | 2415 | 0.050 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2023 | 299 | 0.050 |
Why?
|
Autoantigens | 1 | 2006 | 886 | 0.050 |
Why?
|
Receptors, Peptide | 1 | 2023 | 280 | 0.050 |
Why?
|
Cadherins | 1 | 2006 | 900 | 0.050 |
Why?
|
Lactates | 1 | 2022 | 398 | 0.050 |
Why?
|
Pyruvic Acid | 1 | 2022 | 205 | 0.050 |
Why?
|
Models, Biological | 3 | 2013 | 9445 | 0.050 |
Why?
|
Light | 1 | 2007 | 1358 | 0.050 |
Why?
|
Analysis of Variance | 1 | 2009 | 6208 | 0.050 |
Why?
|
Organ Specificity | 1 | 2006 | 1966 | 0.050 |
Why?
|
Immunoglobulin M | 1 | 2006 | 1527 | 0.040 |
Why?
|
Neurilemmoma | 1 | 2006 | 522 | 0.040 |
Why?
|
Mice, Mutant Strains | 1 | 2003 | 1748 | 0.040 |
Why?
|
Cathepsin H | 1 | 1999 | 10 | 0.040 |
Why?
|
Child | 3 | 2024 | 80573 | 0.040 |
Why?
|
Electromagnetic Phenomena | 1 | 2021 | 159 | 0.040 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2005 | 3445 | 0.040 |
Why?
|
Genomics | 1 | 2015 | 5926 | 0.040 |
Why?
|
Urinary Bladder | 1 | 2005 | 1155 | 0.040 |
Why?
|
Collagen | 2 | 2005 | 2617 | 0.040 |
Why?
|
Histone Deacetylase 2 | 1 | 2019 | 71 | 0.040 |
Why?
|
Angiogenesis Inhibitors | 1 | 2009 | 2046 | 0.040 |
Why?
|
Brain | 3 | 2019 | 27177 | 0.040 |
Why?
|
Cell Differentiation | 2 | 2008 | 11642 | 0.040 |
Why?
|
DNA | 1 | 2013 | 7193 | 0.040 |
Why?
|
Reperfusion Injury | 1 | 2006 | 1043 | 0.040 |
Why?
|
Reference Values | 1 | 2006 | 4909 | 0.040 |
Why?
|
TOR Serine-Threonine Kinases | 3 | 2013 | 2057 | 0.040 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2006 | 2946 | 0.040 |
Why?
|
Complement System Proteins | 1 | 2002 | 716 | 0.040 |
Why?
|
RNA Interference | 1 | 2007 | 2828 | 0.040 |
Why?
|
Histone Deacetylase 1 | 1 | 2019 | 133 | 0.040 |
Why?
|
Particle Size | 3 | 2013 | 1630 | 0.040 |
Why?
|
Organizational Objectives | 1 | 2020 | 426 | 0.040 |
Why?
|
Pancreas | 1 | 2005 | 1699 | 0.040 |
Why?
|
Adamantane | 1 | 2019 | 148 | 0.040 |
Why?
|
Receptors, Transferrin | 1 | 2000 | 300 | 0.040 |
Why?
|
Genetic Techniques | 1 | 2001 | 429 | 0.040 |
Why?
|
RNA, Small Interfering | 1 | 2007 | 3424 | 0.040 |
Why?
|
Sarcoma | 1 | 2009 | 1801 | 0.040 |
Why?
|
Killer Cells, Natural | 1 | 2007 | 2206 | 0.040 |
Why?
|
Islets of Langerhans | 1 | 2004 | 1349 | 0.040 |
Why?
|
Cell Movement | 2 | 2008 | 5196 | 0.040 |
Why?
|
Folic Acid | 1 | 2005 | 1337 | 0.040 |
Why?
|
Arteriosclerosis | 1 | 2002 | 1055 | 0.040 |
Why?
|
Infrared Rays | 1 | 1999 | 246 | 0.040 |
Why?
|
Tuberous Sclerosis | 1 | 2005 | 1039 | 0.040 |
Why?
|
Kallikreins | 1 | 2019 | 219 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2022 | 2455 | 0.040 |
Why?
|
Standard of Care | 1 | 2022 | 568 | 0.040 |
Why?
|
Interleukin-1beta | 2 | 2015 | 1028 | 0.040 |
Why?
|
Computational Biology | 2 | 2009 | 3565 | 0.040 |
Why?
|
Central Nervous System Neoplasms | 1 | 2006 | 918 | 0.040 |
Why?
|
Oligopeptides | 2 | 2000 | 1195 | 0.040 |
Why?
|
Anilides | 1 | 2020 | 413 | 0.030 |
Why?
|
Phosphocreatine | 2 | 1995 | 259 | 0.030 |
Why?
|
Cysteine Endopeptidases | 1 | 1999 | 542 | 0.030 |
Why?
|
Health Services Accessibility | 1 | 2014 | 5510 | 0.030 |
Why?
|
Phosphorylcholine | 2 | 1994 | 151 | 0.030 |
Why?
|
Patient Care | 1 | 2022 | 630 | 0.030 |
Why?
|
Methylthioinosine | 1 | 1996 | 4 | 0.030 |
Why?
|
Phosphonoacetic Acid | 1 | 1996 | 54 | 0.030 |
Why?
|
Epithelial Cells | 1 | 2008 | 3684 | 0.030 |
Why?
|
Seizures | 1 | 2009 | 2997 | 0.030 |
Why?
|
Organophosphorus Compounds | 1 | 1997 | 209 | 0.030 |
Why?
|
Lactams | 1 | 2017 | 159 | 0.030 |
Why?
|
Hydroxamic Acids | 1 | 2019 | 483 | 0.030 |
Why?
|
Hormones | 1 | 2020 | 865 | 0.030 |
Why?
|
Lymph Nodes | 2 | 2010 | 3456 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2023 | 1852 | 0.030 |
Why?
|
Iron | 1 | 2004 | 1811 | 0.030 |
Why?
|
Dendritic Cells | 1 | 2007 | 2747 | 0.030 |
Why?
|
Phosphatidylcholines | 1 | 1997 | 403 | 0.030 |
Why?
|
Pelvis | 1 | 2020 | 737 | 0.030 |
Why?
|
Mutation | 5 | 2013 | 30209 | 0.030 |
Why?
|
Hypoglycemic Agents | 1 | 2008 | 3107 | 0.030 |
Why?
|
Isotope Labeling | 1 | 2017 | 390 | 0.030 |
Why?
|
Choline | 1 | 1997 | 511 | 0.030 |
Why?
|
Deoxyuracil Nucleotides | 1 | 1995 | 13 | 0.030 |
Why?
|
Tumor Suppressor Proteins | 1 | 2005 | 2795 | 0.030 |
Why?
|
Dose-Response Relationship, Radiation | 2 | 1994 | 870 | 0.030 |
Why?
|
Receptors, Cell Surface | 1 | 2005 | 2815 | 0.030 |
Why?
|
Technology, Radiologic | 1 | 1995 | 158 | 0.030 |
Why?
|
Cyclophosphamide | 2 | 2005 | 2232 | 0.030 |
Why?
|
Fractures, Bone | 1 | 2007 | 2041 | 0.030 |
Why?
|
Proteomics | 1 | 2009 | 3907 | 0.030 |
Why?
|
Peptide Library | 2 | 2008 | 351 | 0.030 |
Why?
|
Genetic Engineering | 2 | 2013 | 933 | 0.030 |
Why?
|
Virus Replication | 1 | 2023 | 2458 | 0.030 |
Why?
|
Biophysical Phenomena | 1 | 1995 | 318 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 2 | 2009 | 548 | 0.030 |
Why?
|
Ki-67 Antigen | 1 | 2017 | 628 | 0.030 |
Why?
|
Quinolines | 2 | 2013 | 769 | 0.030 |
Why?
|
Melanoma, Amelanotic | 1 | 2014 | 19 | 0.030 |
Why?
|
Phosphates | 2 | 1995 | 763 | 0.030 |
Why?
|
Flow Cytometry | 2 | 2020 | 5881 | 0.030 |
Why?
|
Intestinal Mucosa | 1 | 2005 | 3048 | 0.030 |
Why?
|
Phospholipids | 2 | 1995 | 776 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2018 | 6506 | 0.030 |
Why?
|
Biophysics | 1 | 1995 | 375 | 0.030 |
Why?
|
Down-Regulation | 2 | 2014 | 2927 | 0.030 |
Why?
|
MAP Kinase Signaling System | 2 | 2013 | 1490 | 0.030 |
Why?
|
Joints | 2 | 2007 | 321 | 0.030 |
Why?
|
Membrane Lipids | 1 | 1995 | 240 | 0.030 |
Why?
|
Aspartic Acid | 1 | 1996 | 575 | 0.030 |
Why?
|
Nepal | 1 | 2014 | 302 | 0.030 |
Why?
|
Esters | 1 | 1994 | 213 | 0.030 |
Why?
|
Aminopyridines | 1 | 2017 | 576 | 0.030 |
Why?
|
Vero Cells | 1 | 2014 | 486 | 0.030 |
Why?
|
Serum | 1 | 2014 | 205 | 0.030 |
Why?
|
Paralysis | 1 | 2014 | 248 | 0.030 |
Why?
|
MutS Homolog 2 Protein | 1 | 2013 | 200 | 0.030 |
Why?
|
Ganciclovir | 1 | 2013 | 256 | 0.030 |
Why?
|
Synovial Fluid | 2 | 2005 | 386 | 0.030 |
Why?
|
Substrate Specificity | 3 | 2002 | 1751 | 0.030 |
Why?
|
Menisci, Tibial | 1 | 2015 | 266 | 0.030 |
Why?
|
Tumor Burden | 1 | 2018 | 1889 | 0.030 |
Why?
|
Point-of-Care Systems | 1 | 2021 | 1218 | 0.020 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2013 | 195 | 0.020 |
Why?
|
Microscopy, Atomic Force | 1 | 2013 | 250 | 0.020 |
Why?
|
Tamoxifen | 1 | 2016 | 964 | 0.020 |
Why?
|
Receptors, Progesterone | 1 | 2017 | 1152 | 0.020 |
Why?
|
Organic Chemicals | 1 | 2013 | 211 | 0.020 |
Why?
|
Nucleotides | 1 | 1994 | 453 | 0.020 |
Why?
|
Glycolysis | 1 | 1996 | 837 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2005 | 4910 | 0.020 |
Why?
|
Bone Morphogenetic Protein 4 | 1 | 2012 | 163 | 0.020 |
Why?
|
Drug Screening Assays, Antitumor | 2 | 2009 | 715 | 0.020 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 1995 | 614 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2007 | 15403 | 0.020 |
Why?
|
Follow-Up Studies | 3 | 2018 | 39243 | 0.020 |
Why?
|
Ankle | 1 | 2014 | 353 | 0.020 |
Why?
|
Metaplasia | 1 | 2012 | 325 | 0.020 |
Why?
|
Integrases | 1 | 2013 | 520 | 0.020 |
Why?
|
Prostate | 1 | 2019 | 1758 | 0.020 |
Why?
|
Adolescent | 4 | 2023 | 88819 | 0.020 |
Why?
|
Salvage Therapy | 1 | 2017 | 1273 | 0.020 |
Why?
|
Macaca mulatta | 1 | 2017 | 2341 | 0.020 |
Why?
|
Young Adult | 4 | 2019 | 59868 | 0.020 |
Why?
|
Radiotherapy, Intensity-Modulated | 1 | 2016 | 781 | 0.020 |
Why?
|
Polylysine | 2 | 2000 | 130 | 0.020 |
Why?
|
Homeodomain Proteins | 2 | 2012 | 2430 | 0.020 |
Why?
|
Sex Distribution | 1 | 2014 | 2270 | 0.020 |
Why?
|
Tissue Donors | 1 | 2019 | 2392 | 0.020 |
Why?
|
ran GTP-Binding Protein | 1 | 2009 | 53 | 0.020 |
Why?
|
Wnt Proteins | 1 | 2013 | 721 | 0.020 |
Why?
|
Microspheres | 2 | 2002 | 773 | 0.020 |
Why?
|
Prostatectomy | 1 | 2017 | 1786 | 0.020 |
Why?
|
Viral Load | 1 | 2018 | 3386 | 0.020 |
Why?
|
Luminescence | 1 | 2009 | 109 | 0.020 |
Why?
|
Age Distribution | 1 | 2014 | 2865 | 0.020 |
Why?
|
Receptor, Notch1 | 1 | 2012 | 516 | 0.020 |
Why?
|
Ear | 1 | 2009 | 172 | 0.020 |
Why?
|
Uteroglobin | 1 | 2008 | 55 | 0.020 |
Why?
|
Cell Division | 1 | 1996 | 4466 | 0.020 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2009 | 183 | 0.020 |
Why?
|
Mucins | 1 | 2012 | 568 | 0.020 |
Why?
|
Genotype | 2 | 2013 | 13028 | 0.020 |
Why?
|
Aging | 1 | 2007 | 8723 | 0.020 |
Why?
|
Pyridines | 1 | 2020 | 2889 | 0.020 |
Why?
|
Bromodeoxyuridine | 1 | 2008 | 310 | 0.020 |
Why?
|
Employment | 1 | 2014 | 1108 | 0.020 |
Why?
|
Gene Rearrangement | 1 | 2013 | 1143 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2013 | 1241 | 0.020 |
Why?
|
Esophageal Diseases | 1 | 2008 | 167 | 0.020 |
Why?
|
Lactic Acid | 1 | 2013 | 1137 | 0.020 |
Why?
|
DNA, Neoplasm | 1 | 2013 | 1739 | 0.020 |
Why?
|
Emotions | 1 | 2019 | 2758 | 0.020 |
Why?
|
Imidazoles | 1 | 2013 | 1169 | 0.020 |
Why?
|
Educational Status | 1 | 2014 | 2510 | 0.020 |
Why?
|
Patient Selection | 1 | 2019 | 4249 | 0.020 |
Why?
|
Urban Population | 1 | 2014 | 2040 | 0.020 |
Why?
|
Muscle Proteins | 1 | 2012 | 1160 | 0.020 |
Why?
|
Mesoderm | 1 | 2009 | 679 | 0.020 |
Why?
|
Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2006 | 83 | 0.020 |
Why?
|
Treatment Failure | 1 | 2012 | 2653 | 0.020 |
Why?
|
Erythrocyte Volume | 1 | 2005 | 28 | 0.020 |
Why?
|
Neural Cell Adhesion Molecules | 1 | 2006 | 122 | 0.020 |
Why?
|
Radiation Dosage | 1 | 1994 | 1945 | 0.020 |
Why?
|
Adherens Junctions | 1 | 2006 | 90 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2013 | 2718 | 0.020 |
Why?
|
Genes, ras | 1 | 2008 | 656 | 0.020 |
Why?
|
PPAR gamma | 1 | 2008 | 484 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2009 | 1336 | 0.020 |
Why?
|
DNA, Recombinant | 1 | 2006 | 455 | 0.020 |
Why?
|
Folate Receptors, GPI-Anchored | 1 | 2005 | 23 | 0.020 |
Why?
|
Immune Tolerance | 1 | 2014 | 2324 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2017 | 4521 | 0.010 |
Why?
|
Random Allocation | 1 | 2009 | 2395 | 0.010 |
Why?
|
Interleukin-12 | 1 | 2007 | 581 | 0.010 |
Why?
|
Phenotype | 2 | 2017 | 16716 | 0.010 |
Why?
|
Lentivirus | 1 | 2007 | 518 | 0.010 |
Why?
|
Oligonucleotides | 1 | 2007 | 561 | 0.010 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2008 | 904 | 0.010 |
Why?
|
Plasmids | 1 | 2009 | 2267 | 0.010 |
Why?
|
Binding Sites | 1 | 2013 | 6001 | 0.010 |
Why?
|
Histamine | 1 | 2006 | 495 | 0.010 |
Why?
|
Antigen-Antibody Complex | 1 | 2006 | 508 | 0.010 |
Why?
|
Epithelium | 1 | 2008 | 1604 | 0.010 |
Why?
|
Rural Population | 1 | 2014 | 2318 | 0.010 |
Why?
|
Jejunum | 1 | 2006 | 474 | 0.010 |
Why?
|
Blood Proteins | 1 | 2009 | 1186 | 0.010 |
Why?
|
Blood Vessels | 1 | 2009 | 1113 | 0.010 |
Why?
|
Cohort Studies | 2 | 2020 | 41684 | 0.010 |
Why?
|
Computer Security | 1 | 2005 | 261 | 0.010 |
Why?
|
Hospitalization | 1 | 2023 | 10811 | 0.010 |
Why?
|
Radionuclide Angiography | 1 | 2002 | 23 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2000 | 4565 | 0.010 |
Why?
|
Gated Blood-Pool Imaging | 1 | 2002 | 43 | 0.010 |
Why?
|
Fibrosarcoma | 2 | 1996 | 312 | 0.010 |
Why?
|
Subcellular Fractions | 1 | 2003 | 528 | 0.010 |
Why?
|
Gamma Cameras | 1 | 2002 | 35 | 0.010 |
Why?
|
Transduction, Genetic | 1 | 2005 | 898 | 0.010 |
Why?
|
Rats, Inbred F344 | 1 | 2003 | 820 | 0.010 |
Why?
|
Magnetics | 1 | 2005 | 586 | 0.010 |
Why?
|
Odds Ratio | 1 | 2014 | 9657 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18386 | 0.010 |
Why?
|
Transgenes | 1 | 2005 | 1014 | 0.010 |
Why?
|
Health Expenditures | 1 | 2014 | 2389 | 0.010 |
Why?
|
Amino Acid Motifs | 1 | 2004 | 924 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2010 | 2890 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2019 | 4863 | 0.010 |
Why?
|
Receptor, Anaphylatoxin C5a | 1 | 2002 | 85 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2012 | 3227 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2009 | 2195 | 0.010 |
Why?
|
Chemistry Techniques, Analytical | 1 | 2001 | 48 | 0.010 |
Why?
|
Survival Analysis | 1 | 2014 | 10087 | 0.010 |
Why?
|
Transillumination | 1 | 2001 | 20 | 0.010 |
Why?
|
Receptors, Complement | 1 | 2002 | 240 | 0.010 |
Why?
|
Genes, Tumor Suppressor | 1 | 2005 | 1060 | 0.010 |
Why?
|
Homozygote | 1 | 2006 | 1774 | 0.010 |
Why?
|
Serotonin | 1 | 2006 | 1045 | 0.010 |
Why?
|
Cysts | 1 | 2006 | 684 | 0.010 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2002 | 512 | 0.010 |
Why?
|
Patient Acceptance of Health Care | 1 | 2014 | 3230 | 0.010 |
Why?
|
Muscle, Skeletal | 2 | 2006 | 4959 | 0.010 |
Why?
|
Exons | 1 | 2006 | 2393 | 0.010 |
Why?
|
Kinetics | 2 | 1999 | 6273 | 0.010 |
Why?
|
Logistic Models | 1 | 2014 | 13273 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2005 | 1716 | 0.010 |
Why?
|
Blotting, Western | 1 | 2007 | 5020 | 0.010 |
Why?
|
Macrophages | 2 | 2005 | 5776 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2879 | 0.010 |
Why?
|
Microcirculation | 1 | 2004 | 1282 | 0.010 |
Why?
|
Cell Membrane | 1 | 2009 | 3635 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2006 | 3751 | 0.010 |
Why?
|
Fluorescein-5-isothiocyanate | 1 | 1999 | 219 | 0.010 |
Why?
|
Nitric Oxide Synthase | 1 | 2002 | 911 | 0.010 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2002 | 707 | 0.010 |
Why?
|
Cross-Linking Reagents | 1 | 2002 | 687 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2007 | 3159 | 0.010 |
Why?
|
Magnetic Resonance Angiography | 1 | 2005 | 1429 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 2006 | 1651 | 0.010 |
Why?
|
Administration, Oral | 1 | 2007 | 4016 | 0.010 |
Why?
|
Mast Cells | 1 | 2006 | 1404 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2008 | 6309 | 0.010 |
Why?
|
Gene Deletion | 1 | 2006 | 2667 | 0.010 |
Why?
|
Arginine | 1 | 2002 | 931 | 0.010 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2003 | 733 | 0.010 |
Why?
|
NF-kappa B | 1 | 2007 | 2495 | 0.010 |
Why?
|
Polyethylenes | 1 | 2000 | 289 | 0.010 |
Why?
|
Autoimmunity | 1 | 2006 | 1354 | 0.010 |
Why?
|
Anti-Inflammatory Agents | 1 | 2007 | 1805 | 0.010 |
Why?
|
Prevalence | 1 | 2014 | 15827 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2009 | 3561 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2012 | 12976 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 2005 | 2213 | 0.010 |
Why?
|
Ischemia | 1 | 2006 | 1904 | 0.010 |
Why?
|
Immune System | 1 | 2002 | 799 | 0.010 |
Why?
|
Apolipoproteins E | 1 | 2002 | 1459 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2006 | 3400 | 0.010 |
Why?
|
Models, Animal | 1 | 2002 | 2120 | 0.010 |
Why?
|
Thyroid Gland | 1 | 2002 | 1168 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2009 | 7600 | 0.010 |
Why?
|
Phosphorus Isotopes | 1 | 1995 | 125 | 0.010 |
Why?
|
Carbon Isotopes | 1 | 1996 | 453 | 0.010 |
Why?
|
X-Rays | 1 | 1996 | 309 | 0.010 |
Why?
|
United States | 1 | 2023 | 72920 | 0.010 |
Why?
|
Phosphorylation | 1 | 2005 | 8292 | 0.010 |
Why?
|
Polyethylene Glycols | 1 | 1999 | 1189 | 0.010 |
Why?
|
Immunity, Innate | 1 | 2006 | 3079 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2014 | 26290 | 0.010 |
Why?
|
Leukemia, Experimental | 1 | 1993 | 224 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2005 | 4556 | 0.010 |
Why?
|
Lysosomes | 1 | 1999 | 932 | 0.010 |
Why?
|
Internet | 1 | 2005 | 3107 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2005 | 3586 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2004 | 13400 | 0.010 |
Why?
|
Infant | 1 | 2014 | 36427 | 0.010 |
Why?
|
Transcription Factors | 1 | 2012 | 12130 | 0.010 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 1996 | 540 | 0.010 |
Why?
|
Child, Preschool | 1 | 2014 | 42511 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2004 | 17597 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2000 | 3733 | 0.010 |
Why?
|
Antigens, CD | 1 | 2002 | 4025 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 1999 | 2390 | 0.010 |
Why?
|
Kidney Neoplasms | 1 | 2005 | 4282 | 0.000 |
Why?
|